Home/Altagenics/Dr. Martin Schiller

DM

Dr. Martin Schiller

CEO of Heligenics (Technology Partner)

Therapeutic Areas

Musculoskeletal Geriatrics Oncology Supportive Care Metabolic Disorders

Altagenics Pipeline

Drug	Indication	Phase
Discovery Program (Unnamed)	Sarcopenia (age-related muscle wasting)	Discovery

Leadership Team at Altagenics

Managing Director of GLD Partners LP (Founding Investor)

Media Contact (River North Agency for GLD Partners)

View full Altagenics profile